Results
We clustered the results of the cytokine assays into 5 groups according to the cytokine literature.
The results of the individual Kruskal-Wallis analyses are shown in Table 1.
Table 1. Cytokines in Plasma of Female CFS Patients Compared to Female Healthy Controls.
Pro- inflammatory Cytokines:
A significant elevation in the relative amounts of 4 of 5 pro-inflammatory cytokines in peripheral blood plasma of patients with CFS was found when compared with the controls
Only tumor necrosis factor (TNF)α was unchanged.
In cases, lymphotoxin (LT)α was elevated by 257% and IL-6 by 100% over the controls.
TH2 cytokines:
Both interleukin (IL)-4 and IL-5 were elevated in CFS, with the median of IL-4 240% and of IL-5 95%
higher in cases over controls.
Anti-inflammatory cytokines:
IL-13 was significantly lower (!5%) in CFS patients while IL-10 was not different.
TH1 cytokines:
Median plasma levels of IL-2 and IFNγ in CFS were similar to those in controls. However,
IL-12 was significantly elevated (120%) and IL-15 decreased 15% in cases compared to controls.
IL-8 (CXCL8):
This chemokine was 42% lower in the CFS patients.
TH17 cytokines:
IL-17 and IL-23 were not significantly different in CFS cases compared to controls.
ROC curve analyses
Results for those cytokines that were
significantly higher in the case/control comparison are shown in Figure 1 and Table 2.
Those for cytokines that were
lower in CFS than controls are shown in Figure 2 and Table 3.
Area under the curve (AUC) for IL-5 (0. 84), LTα (0.77), IL-4 (0.77), IL-12 (0.76) indicated good biomarker potential.
Coordinates of the curves for these 4 cytokines are in Additional File 1. The AUC of IL-6 (0.73), IL-15 (0.73), IL-8 (0.69), IL-13 (0.68) IL-1α (0.62), IL-1β (0.62) showed fair potential as biomarkers (Tables 2 and 3).
Additional file 1. Coordinates of the curves for those cytokines with AUC that indicated good biomarker material.
Format: DOC Size: 667KB Download file
This file can be viewed with: Microsoft Word Viewer
Table 2. AUC for Plasma Cytokines Significantly Higher in CFS Cases vs. Controls
Table 3. AUC for Plasma Cytokines Significantly Lower in CFS Cases vs. Controls
Figure 1. ROC curves shows the classification performance of plasma cytokines from CFS cases and healthy controls. Curves are for the 7 cytokines
significantly elevated (p < .05) in cases compared to controls (IL-4, IL-5, IL-12, LTα, IL-1α, IL-1β, and IL-6).
Figure 2. ROC curves show the classification performance of plasma cytokines from CFS cases and healthy controls.
Curves are for the 3 cytokines significantly lower (p < .05) in cases compared to controls (IL-8, IL-13 and IL-15).
http://www.translational-medicine.com/content/7/1/96